CELLINK announces an increase in number of shares and votes
The number of shares and votes in CELLINK AB (publ) (“CELLINK”) have increased as a result of a directed new issue of 57,911 shares of series B which was carried out as a part of the financing for the acquisition of Visikol Corp. The Board of Directors resolved on an issue in kind in May 2021 in accordance with the authorization from the Annual General Meeting held on April 26, 2021. Furthermore, the number of shares and votes have increased as a result of a directed new issue of 301,332 shares of series B which was carried out as a part of the financing for the acquisition of Nanoscribe